Monte Rosa Therapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Monte Rosa Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Monte Rosa Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Monte Rosa Therapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $5.9M | 1.0M | 5.65 |
| 2023-09-30 | $4.0M | 837k | 4.79 |
| 2023-06-30 | $5.6M | 814k | 6.85 |
| 2023-03-31 | $6.3M | 813k | 7.79 |
| 2022-12-31 | $7.6M | 994k | 7.61 |
| 2022-06-30 | $1.2M | 120k | 9.67 |
| 2022-03-31 | $662k | 47k | 14.03 |
| 2021-12-31 | $1.0M | 49k | 20.41 |
| 2021-09-30 | $799k | 38k | 21.28 |
| 2021-06-30 | $2.2M | 96k | 22.70 |